Studies of IL-7, which promotes T cell function, found that IL-7 may confer a survival benefit but in PML secondary to hematologic malignancies and post-transplant immunosuppression patients but not underlying HIV (59, 60). This evidence concerns the gene IL7 and hematologic disorder.